1. Home
  2. MNDY vs DNLI Comparison

MNDY vs DNLI Comparison

Compare MNDY & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo monday.com Ltd.

MNDY

monday.com Ltd.

HOLD

Current Price

$82.78

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$22.71

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDY
DNLI
Founded
2012
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
MNDY
DNLI
Price
$82.78
$22.71
Analyst Decision
Buy
Strong Buy
Analyst Count
26
14
Target Price
$167.65
$34.33
AVG Volume (30 Days)
928.5K
1.8M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.70
N/A
Revenue Next Year
$16.48
$408.85
P/E Ratio
$34.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.50
$12.58
52 Week High
$296.94
$27.30

Technical Indicators

Market Signals
Indicator
MNDY
DNLI
Relative Strength Index (RSI) 55.33 42.79
Support Level $67.84 $18.27
Resistance Level $88.48 $23.27
Average True Range (ATR) 4.12 1.38
MACD 1.07 -0.30
Stochastic Oscillator 76.26 11.57

Price Performance

Historical Comparison
MNDY
DNLI

About MNDY monday.com Ltd.

Monday.com Ltd is an artificial intelligence work platform that runs and orchestrates the core of all work. The platform democratizes access to software, including AI, enabling organizations to easily build applications and work management tools that fit their needs. The cloud-based platform is a no-code and low-code framework built from modular building blocks that are simple enough for anyone to use, yet powerful enough to drive core business across any organization. The platform also integrates with other systems and applications, creating a connective layer for organizations that links departments and bridges information silos. In addition to the core products, it introduced four core Al work capabilities: monday sidekick, monday vibe, monday agents, and workflows.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: